KFDA Outlines Key Initiatives for New Year

Published: 2004-12-30 06:59:00

Updated: 2004-12-30 06:59:00

The Korea Food and Drug Administration (KFDA) has recently communicated its key initiatives for the new year, with an overall aim to enhance safeguards on quality, safety and regulatory measures as applied to the pharmaceutical products.

Key Initiatives:

(a) Quality Improvement of Pharmaceu...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK